VHL and DNA damage repair pathway alterations as potential clinical biomarkers for first-line TKIs in metastatic clear cell renal cell carcinomas.
| Authors： | Zhou J, Wang J, Kong W, Zhang J, Wu X, Huang J, Zheng J, Chen Y, Zhai W, Xue W. |
|---|---|
| PubYear： | 2022 |
| Journal： | Cellular oncology |
